Cosmo is a life science company with a focus on gastrointestinal diseases, dermatology and healthtech. We develop and manufacture products which are distributed globally by our partners.
Proprietary technology
The Company’s extensive galenic experience, which led to the development of the proprietary multi-matrix technology MMX®, provides an excellent basis for the development of new, patentable, yet lower-risk products, manufactured at the Company’s own current good manufacturing practices (‘cGMP’) approved plant. Cosmo has a demonstrated ability to successfully identify unmet medical needs, manage the drug development process and obtain regulatory approval for new products. Cosmo then licenses its approved products to partners with strong marketing and sales expertise.
Our target therapies
Cosmo’s therapeutic focus is on the oral and endoscopic treatment of colon diseases, primarily bowel diseases and colorectal cancer prevention. Our MMX® technology allows the delivery of active pharmaceutical ingredients into the lumen of the colon through tablets, in a delayed and controlled way, with the effect that the active pharmaceutical ingredients can be applied to the full length of the colon.